Chromoblastomycosis Treatment Companies

ID: MRFR/Pharma/4230-HCR

120 Pages

Vikita Thakur

Last Updated: February 16, 2025

Chromoblastomycosis is a chronic fungal skin infection that requires specialized medical treatment. Antifungal medications and, in some cases, surgical intervention may be part of the treatment plan.

Chromoblastomycosis Treatment Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)5.89%

2024 Market Size$ 240 Million

2025 Market Size$ 254.14 Million

2035 Market Size$ 450.42 Million

Key Players

Bristol-Myers Squibb

Merck & Co.

Novartis

Pfizer

GSK

Astellas Pharma

Trends

Rising Awareness and Education
Advancements in Therapeutic Options
Integration of Personalized Medicine

Opportunities

Rising Healthcare Expenditure
Increasing Incidence of Chromoblastomycosis
Technological Advancements in Diagnostic Tools

Summary Table of Contents Segmentation Methodology Download PDF

Customize Report

Certified Researchers

Top Industry Leaders in the Chromoblastomycosis Treatment Market

Latest Chromoblastomycosis Treatment Companies Updates

Novartis launches antifungal Posaconazole (Noxafil®) injection in India: This expands accessibility of a potent antifungal medication for chromoblastomycosis treatment in a region with high disease burden.

Eisai announces positive Phase 2b trial results for its investigational antifungal agent E1201 for the treatment of chromoblastomycosis: These promising results offer hope for a new treatment option with potentially improved efficacy and tolerability.

AmplyMed receives FDA Fast Track designation for its investigational antifungal Fumagilin for the treatment of chromoblastomycosis: This designation expedites development and regulatory review, potentially bringing a new treatment option to market faster.

List of Chromoblastomycosis Treatment Key companies in the market:

Astellas Pharma (Japan)
Biocon Limited (India)
Abbott Laboratories (U.S.)
Merck Sharp and Dohme (U.S.)
Gilead Sciences (U.S.)
Mylan Labs (U.S.)
Bristol Myers Squibb (U.S.)
Bayer AG (Germany)
Lonza Group (Switzerland)
Sanofi (France)

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”